Singapore markets open in 7 hours 1 minute
Straits Times Index
3,213.65 -26.93 (-0.83%) S&P 500
3,970.84 +69.48 (+1.78%) Dow
31,904.71 +642.81 (+2.06%) Nasdaq
11,502.59 +147.97 (+1.30%) BTC-USD
30,085.52 +151.67 (+0.51%) CMC Crypto 200
675.81 +0.94 (+0.14%)
Eagle Pharmaceuticals Inc. (1E6.SG)
Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
As of 07:04PM CEST. Market open.
| Previous close | 43.20 |
| Open | 43.20 |
| Bid | 42.40 x 200000 |
| Ask | 43.80 x 200000 |
| Day's range | 42.40 - 43.20 |
| 52-week range | 29.40 - 49.00 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Motley Fool
Eagle Pharmaceuticals (EGRX) Q1 2022 Earnings Call Transcript
At this time, I'd like to welcome everyone to Eagle Pharmaceuticals first quarter 2022 financial results. It is now my pleasure to turn the floor over to Ms. Lisa Wilson, investor relations for Eagle Pharmaceuticals.
- Zacks
Eagle Pharmaceuticals (EGRX) Q1 Earnings Top Estimates
Eagle Pharmaceuticals (EGRX) delivered earnings and revenue surprises of 3.32% and 5.32%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
TEVA Matches Q1 Earnings Estimates, Lowers 2022 Sales View
TEVA reports in-line Q1 earnings but misses estimates for sales. It lowers its sales expectations for 2022 while keeping the adjusted earnings per share guidance intact.
© 2022 Yahoo. All rights reserved.
